ClinicalTrials.govpublic full text
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
solid tumors, soft-tissue sarcoma, breast cancer, advanced soft-tissue sarcoma, advanced breast cancer, maximum tolerated dose, efficacy and safety, immunotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850135
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.